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Abstract
Purpose The purpose of this study was to evaluate the clinical
and radiological outcome following compression plate fixa-
tion in combination with autologous bone grafting, with and
without additional application of recombinant human bone
morphogenetic protein (rhBMP) for treatment of aseptic clav-
icle non-union.
Methods Between April 2004 and April 2015, 82 patients
were treated for clavicle fracture and had developed aseptic
clavicle non-union. Seventy-three out of 82 patients were
available for follow-up at least one year after revision surgery;
among them, 27 women and 46 men, with a median age of 49
(range, 19–86) years. Forty-five patients received compres-
sion plate osteosynthesis with autologous bone grafting, and
28 patients obtained compression plate fixation with autolo-
gous bone grafting and additional application of rhBMP-2
(3/28 patients) or rhBMP-7 (25/28 patients).
Results Seventy out of 73 non-unions (96 %) healed within
12 months after revision surgery. Functional outcome accord-
ing to the DASH Outcome Measure (with rhBMP, 33.16 ±
1.17 points; without rhBMP, 30.58 ± 2.12 points [mean ±
SEM]; p = 0.81), non-union healing (p = 0.86), time interval
between revision surgery and bone healing (p = 0.37), as well
as post-operative complications, did not demonstrate relevant
differences between the treatment groups and were not age-
dependent.
Discussion Functional and radiological results demonstrate
that successful healing of aseptic clavicle non-union is depen-
dent on radical resection of non-union tissue, restoration of
length of the shoulder girdle and application of stable
locking-plate osteosynthesis in combination with autologous
bone grafting, but not dependent on application of additional
rhBMP.
Keywords Non-union . Clavicle . Bonemorphogenetic
protein . rhBMP-2 . rhBMP-7 . Locking compression plate .
Bone graft . DASHOutcomeMeasure
Introduction
About 5 % of all fractures in adults involve the clavicle, and
most of them are located in the middle third of the shaft [1, 2].
Historically, conservative treatment was recommended for
clavicle fractures. However, the majority of these fractures
are characterised by displacement of fracture fragments.
Recent literature reports an increased risk of symptomatic
non-union for comminuted clavicle fractures following con-
servative as well as surgical treatment including plate
osteosynthesis or intramedullary fixation using pins, screws,
wires or nails [2]. Approximately one-third of the complica-
tions may be avoided by choosing the adequate surgical treat-
ment option [3]. Reliable data are not available, but it is com-
mon consensus that symptomatic non-union of clavicle frac-
tures in adults characterised by local tenderness at the non-
union site and pain with shoulder motion is relatively rare [4].
Significant risk factors including drug abuse, diabetes and
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previous surgery of the shoulder have been identified to con-
tribute to the development of non-union or fixation failure [5].
Non-union of clavicle fractures remains a devastating problem
in terms of the anatomical configuration and function of the
shoulder girdle, and there is still no Bgold standard^ for oper-
ative treatment. Therefore, surgical treatment is complex,
technically challenging and may not be cost-effective [6].
Earlier studies demonstrated that treatment of clavicle non-
union using classic surgical techniques of straight or pre-
contoured compression plate osteosynthesis and autologous
bone grafting resulted in relatively high clinical and radiolog-
ical union rates [7]. In symptomatic clavicle non-union or
malunion, restoration of the anatomic bone configuration is
a mandatory precondition to induce solid osseous healing.
Anatomical restoration of length is achieved by performing
an osteotomy of the malunited site, followed by application
of autologous bone graft and rigid compression plate
osteosynthesis. In principal, interposition of autologous bone
grafting is a successful tool for the reconstruction of segmental
bone loss [8]. Biological augmentation with autologous non-
vascularised corticocancellous, cancellous or vascularised
grafts, is an important option for successful treatment of
non-union, despite increased donor site morbidity [9, 10]. In
this context, only a few case reports have assessed the addi-
tional application of recombinant human bone morphogenetic
protein (rhBMP) in the upper extremity [11, 12].
In this cohort study, the surgical revision concept of open
compression plating and autologous bone grafting, with and
without additional use of rhBMP, for the treatment of aseptic
clavicle non-union was evaluated to determine if osseous
healing of aseptic clavicle non-union occurred more frequent-
ly, time to bone healing was shorter, and clinical and radiolog-
ical outcome was better following additional application of
rhBMP compared with no rhBMP application.
Patients and methods
In an 11-year period between April 2004 and April 2015, a
retrospective cohort study was performed in a level-1 trauma
centre.
Inclusion criteria for the study were as follows:
& Patients over 18 years of age or skeletal maturity at time of
surgical revision.
& Open or closed clavicle fracture with initial conservative
or operative treatment.
& Development of aseptic clavicle non-union requiring revi-
sion procedure a minimum of 4 months after initial frac-
ture treatment.
The exclusion criteria included:
& Patients younger than 18 years.
& Patients with skeletal immaturity or congenital forms of
clavicle non-union.
& Septic clavicle non-union with previous or consecutive
proof of bacterial growth at the site of interest.
& Non-union following pathological clavicle fracture or
caused by previously dystrophic bone.
& Any specific contraindication to the utilisation of rhBMP-
2 or rhBMP-7, such as allergy.
& Patients unable to give a written informed consent for the
study.
& Patients with an increased risk for elective operative treat-
ment according to theAmerican Society of Anesthesiologists
(ASA) grade >3 [13].
Fractures were classified according to the Allman classifi-
cation (Table 1) [1]. Fracture healing was defined using the
following clinical and radiological outcome parameters: abil-
ity to perform weight-bearing without pain, stability at non-
union site, the formation of callus at all four cortices
(Heckman’s criteria of fracture healing) and the elimination
of fracture lines [14]. If fracture healing was not clearly visible
on X-ray imaging, a computed-tomography scan was per-
formed to detect radiological non-union. The modern defini-
tion of a non-union used in this study is the point of time when
normal bone healing processes ceased to the extent that union
cannot occur without any additional operative intervention
[15].
Standard surgical technique: locking compression plate
and autologous bone graft
In the surgical procedure, the previous surgical approach
was used and optionally extended to explore the non-
union site. Implants were removed, and devitalised tis-
sue was extensively debrided until normal viable osse-
ous and soft tissue margins were obtained. Specimens
were sent for cultures after removing the initial hard-
ware. Three different diagnostic methods (culture of tis-
sue samples, culture of intraoperative swabs, histopa-
thology of tissue samples) were compared. Biological
augmentation involved radical resection of fibrous non-
union tissue and application of autologous bone graft.
The material was predominately harvested from the iliac
crest, or locally from hypertrophic bone formation at the
non-union site. For correct restoration of clavicle length,
interposition of autologous bone graft was required.
For stabilisation of both the non-union and the autolo-
gous bone graft interposition, rigid compression plate
osteosynthesis using a long, bridging locking compres-
sion plate (LCP) was performed irrespective of the lo-
cation of clavicle fracture (medial, middle or lateral
third).
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Additional rhBMP application
Additional application of rhBMPs in this study was conducted
using rhBMP-7 (OP-1®; Stryker Biotech, Kalamazoo, MI,
USA) from 2004 until April 2013, or rhBMP-2 (InductOs®;
Medtronic Biopharma, Heerlen, The Netherlands) starting in
May 2013. One complete unit of rhBMP-2 or rhBMP-7 was
applied to the non-union area according to manufacturer’s
instructions in each case. The decision to utilise rhBMP was
dependent on the intraoperative assessment and the discretion
of the treating orthopaedic trauma surgeon.
Follow-up
After revision surgery, the identical rehabilitation protocol
was conducted with all patients [16]. Follow-up studies were
performed at regular intervals, including one week, six weeks,
three months and six months, as well as at the most recent
office visit to the Department of Orthopaedic Trauma. Follow-
up assessment included thorough physical examination, func-
tional evaluation, and diagnostic radiological studies. The in-
fluence of the treatment outcome on patients’ mental and
physical health status was assessed using the DASH
(Disabilities of the Arm, Shoulder and Hand) Outcome
Measure [17]. Outcome measures are presented as median
values and quartiles.
Statistical analysis
Significance between groups was statistically assessed based
on Mann-Whitney test. Statistical analysis was performed
using IBM SPSS® Statistics for Windows 19.0 (IBM,
Armonk, New York, USA). A result was considered to be
statistically significant with p value <0.05.
Compliance with ethical standards
All procedures performed in this study involving human
participants were in accordance with the bioethical stan-
dards of the institutional and national research commit-
tee (ID, 2016-019) and with the 1964 Helsinki declara-
tion and its later amendments. Written informed consent
was obtained from all individuals participating in the
study. Patients were explicitly informed about the Boff
label^ use of rhBMP-2 and rhBMP-7 [18].
Table 1 Patients’ data overview
Treatment concept Compression plating +
bone grafting
Compression plating +
bone grafting
p value
without rhBMP with rhBMP
Total n = 73 45 28
Cancellous bone grafting (n) 40 19
Iliac crest bone grafting (n) 5 9
Male/female (n) 31/14 15/13
Age (years) 49 (range, 19–65) 50 (range, 20–76)
Index fracture pattern according to the
Allman classification
- medial third (n) 4 2
- middle third (n) 35 23
- lateral third (n) 6 3
Range of time between index and
revision surgery (months)
13 (range, 4–42) 11 (range, 4–50)
Non-union type
- atrophic/oligotrophic (n) 44 25
- hypertrophic (n) 1 3
rhBMP-2 (n) -
-
3
rhBMP-7 (n) 25
Range of time to bone healing (months) 16.6 ± 1.87 19.2 ± 2.13 p = 0.37a
Osseous healing (n) 43 27 p = 0.86b
DASH Outcome Measure (points)
Mean ± SEM 30.58 ± 1.17 33.16 ± 2.11 p = 0.81b
Median 28.0 28.0
Results are presented as mean ± standard error of the mean (SEM) and median
a p value calculated based on Mann-Whitney test, two-tailed
b p value calculated using unpaired t-test, two-tailed
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Results
An overview of all patients included in this study is displayed
in Table 1. Eighty-two patients had been treated with clavicle
fracture and had developed aseptic clavicle non-union (Fig. 1).
Seventy-three out of 82 patients were available for final
follow-up at least one year after revision surgery, among them
27 women and 46 men patients with a median age of 49
(range, 19–86) years. Fifty-three out of 73 patients were re-
ferred from an outside hospital, whereas 20 patients were ini-
tially treated at our institution. Fourteen patients suffered the
clavicle fracture as part of major trauma. Twenty-one patients
suffered a car accident, six patients a motor bike accident, 13
patients a bicycle accident, one patient a ski accident, one
patient a fall from horseback and another patient a fall from
a ladder. Simple falls occurred in 26 patients and a blunt im-
pact in four patients. According to the Allman classification
[1], 57 fractures were located in the middle third, ten were in
the lateral third and six were in the medial third. One patient
had an associated brachial plexus lesion.
The primary treatment for clavicle fracture consisted of
conservative treatment in 33 patients, whereas in 40 patients
primary operative fracture treatment had been performed. For
surgical fracture treatment, 27 one-third tubular plates, six
ESIN nails, one ECMES nail (Fig. 5), one Prevot nail, one
LCP, two tension band fixation and two Hook plates were
used. Hypotrophic and atrophic non-union occurred in 54
and 17 patients, respectively. In two patients, hypertrophic
non-union was found.
Operative non-union therapywas performed by two consul-
tants and their teams after a median time period of 15 months
following the primary fracture treatment. Forty-five patients
received LCP osteosynthesis with autologous bone grafting
(42/45 cancellous bone grafting, Fig. 2; 5/45 iliac crest bone
grafting, Fig. 3) alone and 28 patients received LCP fixation
with autologous bone grafting and additional application of
rhBMP-2 (3/28 patients) or rhBMP-7 (25/28 patients).
With our surgical concept, osseous healing of the clavicle
non-union (Fig. 4) was achieved in 70 out of 73 patients
(96 %) within a time interval of 18 months, on average. In
two patients of the cohort group without additional use of
rhBMP (non-union site: one × medial third, one × lateral third
of the clavicle) and in one patient of the group with additional
use of rhBMP (non-union site: middle third of the clavicle), no
bone healing was observed (p = 0.86). At a median follow-up
of 18 months (range, 6–52 months) shoulder flexion averaged
165° (range, 80–170°), 38° (range, 20–40°) for shoulder ex-
tension, 77° (range, 10–90°) for abduction, 55° (range,
20–60°) for adduction, 55° (range, 20–60°) for internal rota-
tion and 55° (range, 20–60°) for external rotation in all includ-
ed patients. According to the DASH Outcome Measure, there
were no significant differences between the cohort groups
(with rhBMP, 33.16 ± 1.17 points; without rhBMP, 30.58 ±
1.17 points [mean ± SEM]; p = 0.812; Table 1; Fig. 5). Neither
the DASHOutcomeMeasure with rhBMP (Spearman’s Rank-
Order Correlation r = −0.18; p = 0.37) or without rhBMP
(r = −0.13; p = 0.40) application nor the complete non-union
healing with rhBMP (r = 0.09; p = 0.65) or without rhBMP
(r = 0.07; p = 0.65) use was dependent on age. Elective im-
plant removal following complete non-union healing was per-
formed in 33 out of 70 patients. In four patients who had
received operative fracture treatment, breakage of the initial
revision implant (3× LCP, 1× reconstructive plate) occurred.
One out of these non-unions healed in the further course,
Fig. 1 A 67-year-old woman
after a simple fall on the left
clavicle, resulting in a fracture of
the middle third. Development of
aseptic non-union four months
after conservative treatment at an
outside institution
Fig. 2 A 47-year-old woman: insertion of an autologous cancellous bone
graft from iliac crest and fixation with a rigid LCP
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whereas the remaining three non-unions persisted. In two pa-
tients treatedwith additional use of rhBMP-7, impaired wound
healing and inflammation, but no infection, occurred during
the osseous consolidation process after revision surgery with-
out any need for further surgical intervention.
Discussion
Revision rates after operative treatment of clavicle fractures
have been reported to reach up to 25 % [19]. Several of these
surgical interventions are caused by development of delayed
union or non-union at the fracture site. Modern treatment con-
cepts include radical excision of the non-union site, surgical
debridement, open reduction and internal fixation using a rigid
LCP and application of autologous bone graft, with or without
additional administration of rhBMP [20]. Although an in-
creased risk for short-term complications is related to the sur-
gical treatment of clavicle non-union compared with acute
fracture treatment [21], autologous bone graft is commonly
considered to be the safest and most effective grafting proce-
dure, since it contains a patient’s own bone growing cells to
enhance osteogenesis and proteins to enhance osteoinduction,
while providing a matrix for bone ingrowth (osteoconduction)
[8]. In addition, application of autologous bone graft is
performed with the purpose of filling bone defects, and pre-
cisely restoring the length and anatomical alignment of the
clavicle.
It is critical to achieve high osteosynthetic stability. Thus,
bridging plate fixation using an LCP is recommended, and it is
advised to insert three or four screws in each fragment, pref-
erably with bicortical screw fixation. Stabilisation using a
long, bridging plate requires an extended surgical approach
and exposition of the non-union site. Radical resection of
interfragmentary fibrous non-union tissue is mandatory. For
improvement of local non-union biology, it may also be indi-
cated to perform decortication, resection of avital sclerotic
bone and to open a sealed intramedullary canal by using a
small-diameter drill.
For promoting bone healing, additional adjuvant treatment
concepts using rhBMP have been proposed. Although it re-
mains to be determined if the local environment around an
atrophic non-union site is characterised by a deficit of
rhBMP or rhBMP receptors, it has been suggested that topical,
or local application of rhBMP may be beneficial in accelerat-
ing bone healing. Several techniques of rhBMP application
Fig. 3 In the 67-year-old female patient presented in Fig. 1, an
autologous tricortical bone graft from the iliac crest was used in
combination with rhBMP-7 application and rigid LCP fixation
Fig. 4 The 47-year-old female
patient presented in Fig. 2:
elective metal removal following
non-union healing 12 months
after revision surgery
Fig. 5 Functional results according to the DASH Outcome Measure
(points) demonstrated no significant difference between both treatment
groups (p = 0.81; Mann-Whitney test, two-tailed)
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have been utilised including local injection, direct and open
application into the non-union site, or insertion of rhBMP-
coated implants [22]. RhBMPs promote signalling, chemotax-
is, mitosis and differentiation of progenitor cells in the biolog-
ical process of osteogenesis, and have been shown to acceler-
ate bone healing in both settings of fracture and non-union
healing [23]. To our knowledge, this study represents the only
trial of aseptic clavicle non-union treated with additional ap-
plication of both, rhBMP-2 and rhBMP-7, and with at least
one year of functional and radiological follow-up. Clinical and
radiological results of this study demonstrated complete bone
healing in 27 out of 28 patients (96 %) following additional
application of rhBMP-2 or rhBMP-7. Risk of impaired wound
healing and inflammation, but not infection, following appli-
cation of rhBMP was found in our study. The phenomenon of
transient, local soft-tissue inflammation is a typical adverse
effect of rhBMP application. In general, no surgical interven-
tion is required.
A recent study conducted by Morison et al. [24] evaluated
the surgical treatment of aseptic long-bone non-union in the
upper extremity, and concluded that the application of
rhBMP-7 was an effective treatment method with a healing
rate of 92 % (22 out of 24 patients), which was a healing rate
comparable to the results of our study. In contrast to earlier
observations [4, 22], the clinical results of this trial demon-
strated good or excellent overall functional results in both
treatment groups. Furthermore, despite positive effects on
non-union healing in long bones [4, 22] and improved quality
of life with the use of rhBMP-7 [15], our results demonstrated
no significantly increased non-union healing rate or improve-
ment of functional results after additional application of
rhBMP. Some studies have also emphasised economic bene-
fits for rhBMP application in non-union treatment by reducing
overall treatment time and, thus, treatment costs [22, 25, 26].
Even under economic aspects, the results of our study are not
conclusive in order to recommend a general use of rhBMP for
the revision treatment of aseptic clavicle non-union, since the
rate and time to healing was not significantly different be-
tween the two treatment groups. In addition, no relevant cor-
relation between the anatomical localisation of the non-union
site at the clavicle, and treatment was found in our trial.
The limitations of this study include the variety of age of
patients, initial fracture treatment, and time interval between
the fracture and the treatment of the non-union as well as the
sequential nature of the two cohort groups. However, the most
important outcome assessment of this study was to evaluate
the success rate of osseous union using the operative revision
technique as described above. The decision to utilise rhBMP
was dependent on the intra-operative assessment and the dis-
cretion of the treating orthopaedic surgeon, and was not sub-
ject to randomised or blinded protocol. Although it is a retro-
spective investigation, the strengths of the study include the
large number of patients managed according to clear inclusion
and exclusion criteria, with a consistent standard-treatment
protocol in the same hospital by the same group of surgeons
with extensive surgical experience in the treatment of clavicle
non-union.
In conclusion, functional and radiological results of this
study demonstrate that successful bone healing of aseptic
clavicle non-union is dependent on a precise surgical tech-
nique including radical resection of non-union tissue, restora-
tion of length by interposition of autologous bone graft to
prevent shortening of the shoulder girdle and stable locking
compression plate fixation, but is independent of the applica-
tion of additional rhBMP.
Acknowledgments Open access funding provided by Paracelsus
Medical University, Austria.
The corresponding author is grateful for Professor Volker Bühren’s
guidance and support as Medical Director of the Trauma Centre
Murnau during recent years.
Compliance with ethical standards
Conflict of interest The authors declare that they have no conflict of
interest.
Open Access This article is distributed under the terms of the Creative
Commons At t r ibut ion 4 .0 In te rna t ional License (h t tp : / /
creativecommons.org/licenses/by/4.0/), which permits unrestricted use,
distribution, and reproduction in any medium, provided you give appro-
priate credit to the original author(s) and the source, provide a link to the
Creative Commons license, and indicate if changes were made.
References
1. Allman FL Jr (1967) Fractures and ligamentous injuries of the
clavicle and its articulation. J Bone Joint Surg Am 49(4):774–784
2. Wu CL, ChangHC, LuKH (2013) Risk factors for nonunion in 337
displaced midshaft clavicular fractures treated with Knowles pin
fixation. Arch Orthop Trauma Surg 133(1):15–22. doi:10.1007
/s00402-012-1631-3
3. Asadollahi S, Hau RC, Page RS, Richardson M, Edwards ER
(2016) Complications associated with operative fixation of acute
midshaft clavicle fractures. Injury 47(6):1248–1252. doi:10.1016/j.
injury.2016.02.005
4. Rosenberg N, Neumann L, Wallace AW (2007) Functional out-
come of surgical treatment of symptomatic nonunion and malunion
of midshaft clavicle fractures. J Shoulder Elbow Surg 16(5):510–
513. doi:10.1016/j.jse.2006.12.002
5. Ban I, Troelsen A (2016) Risk profile of patients developing non-
union of the clavicle and outcome of treatment-analysis of fifty five
nonunions in seven hundred and twenty nine consecutive fractures.
Int Orthop 40(3):587–593. doi:10.1007/s00264-016-3120-8
6. Dimitriou R, Dahabreh Z, Katsoulis E, Matthews SJ, Branfoot T,
Giannoudis PV (2005) Application of recombinant BMP-7 on per-
sistent upper and lower limb non-unions. Injury 36(Suppl 4):S51–
S59. doi:10.1016/j.injury.2005.10.010
7. Martetschlager F, Gaskill TR, Millett PJ (2013) Management of
clavicle nonunion and malunion. J Shoulder Elbow Surg 22(6):
862–868. doi:10.1016/j.jse.2013.01.022
2344 International Orthopaedics (SICOT) (2016) 40:2339–2345
8. Gómez-Barrena E, Rosset P, Lozano D, Stanovici J, Ermthaller C,
Gerbhard F (2015) Bone fracture healing: cell therapy in delayed
unions and nonunions. Bone 70:93–101. doi:10.1016/j.
bone.2014.07.033
9. Kirchhoff C, Banke IJ, Beirer M, Imhoff AB, Biberthaler P (2013)
Operative management of clavicular non-union: Iliac crest bone
graft and anatomic locking compression plate. Oper Orthop
Traumatol 25(5):483–498. doi:10.1007/s00064-013-0257-0
10. Calkins MS, Burkhalter W, Reyes F (1987) Traumatic segmental
bone defects in the upper extremity. Treatment with exposed grafts
of corticocancellous bone. J Bone Joint Surg Am 69(1):19–27
11. Calori GM, Tagliabue L, Gala L, d’Imporzano M, Peretti G,
Albisetti W (2008) Application of rhBMP-7 and platelet-rich plas-
ma in the treatment of long bone non-unions: a prospective
randomised clinical study on 120 patients. Injury 39(12):1391–
1402. doi:10.1016/j.injury.2008.08.011
12. RongaM, Fagetti A, CantonG, Paiusco E, SuraceMF, Cherubino P
(2013) Clinical applications of growth factors in bone injuries: ex-
perience with BMPs. Injury 44(Suppl 1):S34–S39. doi:10.1016
/S0020-1383(13)70008-1
13. Keats AS (1978) The ASA classification of physical status—a re-
capitulation. Anesthesiology 49:233–236
14. Heckman JD, Ryaby JP, McCabe J, Frey JJ, Kilcoyne RF (1994)
Acceleration of tibial fracture-healing by non-invasive, low-
intensity pulsed ultrasound. J Bone Joint Surg Am 76:26–34
15. Papanagiotou M, Dailiana ZH, Karachalios T, Varitimidis S,
VlychouM, Hantes M, Malizos KN (2015) RhBMP-7 for the treat-
ment of nonunion of fractures of long bones. Bone Joint J 97-B(7):
997–1003. doi:10.1302/0301-620X.97B7.35089
16. Caspari RB, Beach WR (1993) Arthroscopic anterior shoulder
capsulorrhaphy. Sports Med Arthrosc 1(4):237–241
17. Hudak PL, Amadio PC, Bombardier C (1996) Development of an
upper extremity outcomemeasure: the DASH (disabilities of the arm,
shoulder and hand) [corrected]. The Upper Extremity Collaborative
Group (UECG). Am J Ind Med 29(6):602–608. doi:10.1002
/(SICI)1097-0274(199606)29:6<602::AID-AJIM4>3.0.CO;2-L
18. White AP, Vaccaro AR, Hall JA,Whang PG, Friel BC, McKeeMD
(2007) Clinical applications of BMP-7/OP-1 in fractures, non-
unions and spinal fusion. Int Orthop 31(6):735–741
19. Leroux T, Wasserstein D, Henry P, Khoshbin A, Dwyer T, Ogilvie-
Harris D, Mahomed N, Veillette C (2014) Rate of and risk factors
for reoperations after open reduction and internal fixation of
midshaft clavicle fractures: a population-based study in Ontario,
Canada. J Bone Joint Surg Am 96(13):1119–1125. doi:10.2106
/JBJS.M.00607
20. Giannoudis PV, Einhorn TA, Marsh D (2007) Fracture healing: the
diamond concept. Injury 38(Suppl 4):S3–S6
21. McKnight B, Heckmann N, Hill JR, Pannell WC, Mostofi A, Omid
R, Hatch GF (2016) Surgical management of midshaft clavicle
nonunions is associated with a higher rate of short-term complica-
tions compared with acute fractures. J Shoulder Elbow Surg.
doi:10.1016/j.jse.2016.01.028
22. Garrison KR, Shemilt I, Donell S, Ryder JJ, Mugford M, Harvey I,
Song F, Alt V (2010) Bone morphogenetic protein (BMP) for frac-
ture healing in adults. Cochrane Database Syst Rev 6, CD006950.
doi:10.1002/14651858.CD006950.pub2
23. Hausmann M, Ehnert S, Hofmann V, Dobele S, Freude T, Stockle
U, Nussler A (2014) Use of bone morphogenetic proteins (BMPs)
for the treatment of pseudarthroses—efficiency and therapy failure.
Z Orthop Unfall 152(2):144–151. doi:10.1055/s-0034-1368208
24. Morison Z, Vicente M, Schemitsch EH, McKee MD (2016) The
treatment of atrophic, recalcitrant long-bone nonunion in the upper
extremity with human recombinant bone morphogenetic protein-7
(rhBMP-7) and plate fixation: a retrospective review. Injury 47(2):
356–363. doi:10.1016/j.injury.2015.11.035
25. Dahabreh Z, Dimitriou R, Giannoudis PV (2007) Health econom-
ics: a cost analysis of treatment of persistent fracture non-unions
using bone morphogenetic protein-7. Injury 38(3):371–377.
doi:10.1016/j.injury.2006.08.055
26. Blokhuis TJ, Calori GM, Schmidmaier G (2013) Autograft versus
BMPs for the treatment of non-unions: what is the evidence? Injury
44(Suppl 1):S40–S42. doi:10.1016/S0020-1383(13)70009-3
International Orthopaedics (SICOT) (2016) 40:2339–2345 2345
